Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

VIVUS Inc (NASDAQ:VVUS)

1.40
Delayed Data
As of Dec 02
 -0.01 / -0.71%
Today’s Change
0.92
Today|||52-Week Range
1.85
+37.25%
Year-to-Date
5 Top Performing Biotechnology Stocks of November
Dec 01 / Zacks.com - Paid Partner Content
VIVUS (VVUS) Shows Strength: Stock Adds 5.1% in Session
Nov 21 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close1.41
Today’s open1.42
Day’s range1.36 - 1.46
Volume650,844
Average volume (3 months)424,912
Market cap$146.8M
Dividend yield--
Data as of 3:59pm ET, 12/02/2016

Growth & Valuation

Earnings growth (last year)-12.50%
Earnings growth (this year)+54.44%
Earnings growth (next 5 years)+0.84%
Revenue growth (last year)-16.42%
P/E ratioNM
Price/Sales1.11
Price/Book--

Competitors

 Today’s
change
Today’s
% change
ABUSArbutus Biopharma Co...-0.03-0.93%
NYMXNymox Pharmaceutical...+0.03+0.94%
GLYCGlycoMimetics Inc-0.13-2.11%
XENEXenon Pharmaceutical...-0.15-1.89%
Data as of 3:59pm ET, 12/02/2016

Financials

Next reporting dateFebruary 27, 2017
EPS forecast (this quarter)-$0.09
Annual revenue (last year)$95.4M
Annual profit (last year)-$93.1M
Net profit margin-97.57%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chief Executive Officer &
Director
Seth H. Z. Fischer
Chief Financial &
Accounting Officer
Mark K. Oki
Corporate headquarters
Mountain View, California

Forecasts


Search for Jobs